James Shaffer Insider Profile
4 Followers
James Shaffer, VP & Chief Commercial Officer at Halozyme, holds 29.30K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds 54.02K shares in Halozyme (Ticker: HALO).
James Shaffer's Trading History
| EIGRQEiger Biopharmaceuticals | Mar 15, 2021 | ― | Uninformative Buy | ― | $249.02K | |
| HALOHalozyme | Feb 04, 2014 | VP & Chief Commercial Officer | Uninformative Buy | ― | $5.42M |
You May Also Like
James Shaffer insider profile FAQ
What is the percentage of profitable transactions made by James Shaffer?
The percentage of profitable transactions made by James Shaffer is 0%.
What is the average return per transaction made by James Shaffer?
The average return per transaction made by James Shaffer is -61.50%.
What stocks does James Shaffer hold?
James Shaffer holds: HALO, EIGRQ stocks.
What was James Shaffer's most profitable transaction?
James Shaffer’s most profitable transaction was an Informative Buy of EIGRQ stock on August 19, 2016. The return on the trade was -50.40%.
What is James Shaffer's role in Halozyme?
James Shaffer's role in Halozyme is VP & Chief Commercial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
